Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

December 23, 2020

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

December 22, 2020

Short-term Mortality Higher in Transfused TAVR Patients

News Daily News

Short-term Mortality Higher in Transfused TAVR Patients

December 10, 2020

Transradial Access Still Beats Transfemoral for STEMI in Updated Meta-analysis

News Daily News

Transradial Access Still Beats Transfemoral for STEMI in Updated Meta-analysis

November 25, 2020

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

News Daily News

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

November 06, 2020

H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds?

News Daily News

H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds?

November 05, 2020

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

October 29, 2020

More Teamwork, Coordination Could Boost CV Studies in COVID-19

News Daily News

More Teamwork, Coordination Could Boost CV Studies in COVID-19

October 28, 2020

New Review Urges Rethink of Cardiogenic Shock Care

News Daily News

New Review Urges Rethink of Cardiogenic Shock Care

October 27, 2020

Flash-Debate: Which Oral P2Y12 Inhibitor in ACS Treated With PCI? - Clopidogrel for Most!

Presentation TCT 2020

Clopidogrel for Most!

Presenter: John Bittl

October 15, 2020

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Presentation TCT 2020

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Presenter: Jose de la Torre Hernandez

October 14, 2020

TCT 058: Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial

Presentation TCT 2020

TCT 058: Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial

Presenter: Benjamin Peterson

October 14, 2020

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

October 09, 2020

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

October 08, 2020

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

News Daily News

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Michael O'Riordan

October 02, 2020

Study Affirms Thrombotic Risk in COVID-19

News Daily News

Study Affirms Thrombotic Risk in COVID-19

October 01, 2020

Aspirin Alone After TAVR Supported by Meta-analysis

News Daily News

Aspirin Alone After TAVR Supported by Meta-analysis

September 29, 2020

ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin

News Daily News

ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin

September 21, 2020

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

September 04, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.